ResearcherMedical College of WisconsinActive in the last 2 years

Madeline M. Dzikowski

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5097902692. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

PRMT5 inhibition triggers functional ATM deficiency and sensitizes pancreatic cancer to CHK1 blockade. Co-author DOI 10.3389/fcell.2026.1748541 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Michael T. Zimmermann · 1 shared paper, 2026 · strength 0.29
- Paper PRMT5 inhibition triggers functional ATM deficiency and sensitizes pancreatic cancer to CHK1 blockade. DOI 10.3389/fcell.2026.1748541 ↗
Gareth Pollin · 1 shared paper, 2026 · strength 0.29
- Paper PRMT5 inhibition triggers functional ATM deficiency and sensitizes pancreatic cancer to CHK1 blockade. DOI 10.3389/fcell.2026.1748541 ↗
Raul A. Urrutia · 1 shared paper, 2026 · strength 0.29
- Paper PRMT5 inhibition triggers functional ATM deficiency and sensitizes pancreatic cancer to CHK1 blockade. DOI 10.3389/fcell.2026.1748541 ↗
Gwen Alyce Lomberk · 1 shared paper, 2026 · strength 0.29
- Paper PRMT5 inhibition triggers functional ATM deficiency and sensitizes pancreatic cancer to CHK1 blockade. DOI 10.3389/fcell.2026.1748541 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.